IRIS
Chiappini, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 221
AS - Asia 143
NA - Nord America 38
AF - Africa 4
SA - Sud America 2
Totale 408
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 193
SG - Singapore 85
HK - Hong Kong 27
US - Stati Uniti d'America 20
MX - Messico 14
PH - Filippine 12
PK - Pakistan 7
DE - Germania 6
CA - Canada 4
FR - Francia 4
GH - Ghana 4
IN - India 4
JO - Giordania 3
NL - Olanda 3
RO - Romania 3
AL - Albania 2
BR - Brasile 2
FI - Finlandia 2
GB - Regno Unito 2
UA - Ucraina 2
YE - Yemen 2
ES - Italia 1
HR - Croazia 1
ID - Indonesia 1
IE - Irlanda 1
NP - Nepal 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 408
Salva come PNG Salva come JPEG
Città #
Rome 159
Singapore 34
Hong Kong 24
Mexico City 14
Karachi 5
Accra 4
Benevento 4
Santa Clara 4
Amman 3
Ashburn 3
Bucharest 3
Manila 3
Naples 3
Paranaque City 3
Sermoneta 3
Boydton 2
Delhi 2
Florence 2
Hamilton 2
Milan 2
Mumbai 2
Novara 2
Quezon City 2
San Juan 2
Sanaa 2
Tirana 2
Toronto 2
Villa Raspa 2
Berlin 1
Bologna 1
Brasília 1
Dublin 1
Makati City 1
Moscow 1
New Brunswick 1
Phuket 1
San Diego 1
Santa Isabel 1
Warrington 1
Totale 306
Salva come PNG Salva come JPEG
Nome #
Understanding the use of prescription and OTC drugs in obtaining highs and the pharmacist role in preventing abuse 44
Le nuove sostanze psicoattive 18
'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports 13
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): An Analysis of Pharmacovigilance Databases 10
Gestione dei pazienti con depressione resistente al trattamento in comorbilità con il disturbo da uso di sostanze: sicurezza ed efficacia dell'esketamina in un sottocampione di pazienti dello studio REAL-ESK 10
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 10
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 10
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review 8
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 8
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 7
Beyond the ‘purple drank’. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports 7
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 6
Ibogaine/Noribogaine in the treatment of Substance Use Disorders: a systematic review and Meta-analysis of side effects 6
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 6
New/emerging psychoactive substances and associated psychopathological consequences. 6
Beyond the purple drank. Study of promethazine abuse according to the Eurovigilance dataset 6
Psychobiological, medical, and psychiatric implications of new/novel psychoactive substance (NPS) use 6
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 6
An Update on Psychoactive Substances: Pharmacology and Toxicology Issues 6
An insight into Z-drugs abuse and dependence: an examination of reports to the European Medicines Agency (EMA) database of suspected Adverse Drug Reactions (ADR) 5
The e-psychonaut drugs' psychopharmacology 5
Knowledge and use of over-the-counter drugs in Italy: an exploratory survey-based study in the general population 5
Addiction: a therapeutic model for the restructuring of identity 5
A decade of gabapentinoid misuse: an analysis of the European Medicines Agency's ‘suspected adverse drug reactions' database. Assessment of gabapentinoid misuse/dependence as reported to the EMA 5
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 5
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 5
A multidisciplinary approach for addiction treatment in an Italian day hospital service: a therapy model and its goals 4
Assessing The 2004-2018 Fentanyl Misusing Issues Reported To An International Range Of Adverse Reporting Systems 4
Alprazolam-related deaths in Scotland, 2004-2020 4
2876 – Glutamatergic strategies in the treatment of pathological gambling: a pilot study 4
Pharmacovigilance signals of the opioid epidemic over 10 years: an analysis of pharmacovigilance datasets collecting Adverse Drug Reactions (ADRs) reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS) 4
Opioid painkiller dependence in a sample of elderly medical inpatients 4
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 4
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy 4
Nuove frontiere nell'abuso di sostanze, psiconauti e internet 4
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 4
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 4
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 4
Behavioural Addictions In Adolescence: Findings From An Italian Survey 4
‘Z-trip'? A comprehensive overview and and a case-series of Zolpidem misuse 4
Pregabalin treatment in pathological gambling: a preliminary study 4
COVID-19: The hidden impact on mental health and drug addiction 4
ARE Z-DRUGS SAFE? STUDY OF THEIR MISUSE, ABUSE AND DEPENDENCE ACCORDING TO THE EUROPEAN MEDICINES AGENCY (EMA) PHARMACOVIGILANCE DATABASE. 4
Substance-Use Disorders and Violence 4
Age in Pathological Gambling: Correlations with Personality and Psychiatric Comorbidity. 4
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 3
Methoxetamine: An Analogue of Ketamine 3
Special M related fatalities in the UK. 3
Evaluation of an italian sample of gamblers with dannon ainhold gambling scale: preliminary study 3
Pregabalin: a range of misuse-related unanswered questions 3
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 3
The Unregulated Psychoactive Compound: ‘Benzo Fury' 3
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 3
The misuse of prescription drugs in the digital era: pros and cons 3
NPS stimulants 3
The benzydamine experience: a systematic review of benzydamine abuse 3
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 3
Misuse and Abuse of Prescription Drugs in Custodial Settings 3
Evaluating craving in Alcohol Use Disorder: psychometric characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 3
Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 3
Efficacy of psychosocial and psychological interventions in addition to drug therapy to improve global functioning of inpatients with schizophrenia spectrum and mood disorders: a real-world observational study 3
Climate change, biodiversity loss and mental health: a global perspective 3
The opioid epidemic over the past 10 years: pharmacovigilance signals from the European Medicines Agency (EMA) and the FDA Adverse Event Reporting System (FAERS) 3
Behavioural changes in cocaine dependent patients after group-therapy 3
Utilizzo del pregabalin nel trattamento del gioco d'azzardo patologico: dati preliminari 3
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 3
Relationship between impulsivity, mood disorders and personality traits in a sample of pathological gamblers 3
What about “pharming”? Issues regarding the misuse of prescription and over-the-counter drugs 2
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database 2
The bridge between classical and ‘synthetic'/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective 2
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 2
Cannabis: evidenze epidemiologiche, cliniche e terapeutiche 2
Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports 2
Cannabidiol (CBD) Use in Psychiatric Disorders: a Systematic Review 2
Misuse of Anticholinergic Medications: A Systematic Review 2
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality. 2
Compulsiveness dimension in a case of pathological gambling 2
Brexpiprazole as a new approach of treatment in somatization disorder 2
Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel 2
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 2
The role of novel psychoactive substances (NPS) in mental health care of young people: a systematic review 2
Is there a potential of misuse for quetiapine? Literature review and analysis of the European Medicines Agency/EMA Adverse Drug Reactions' database 2
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 2
Fatalities Associated with Mephedrone in Combination with Other Stimulant Drugs in Young People Aged 16-24 Years 2
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 2
There is a potential of misuse for venlafaxine and bupropion? 2
Online Gambling, Impulsivity and Personality Traits: an Italian Sample 2
Psychosocial risk factors for postpartum depression: a descriptive sample of pregnants 2
New psychoactive substances and suicidality: A systematic review of the current literature 2
Loperamide diversion and abuse: assessment of its non-medical use through the analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 2
New psychoactive substances (NPS), psychedelic experiences, and dissociation; clinical and clinical pharmacological issues. 1
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. 1
β-2 agonists as misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency (EMA) Pharmacovigilance Database Reports. 1
Mobile phone use during adolescence: a new addiction? 1
Validation of a diagnostic questionnaire based on DSM-IV criteria for gambling. 1
Totale 421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025420 21 102 3 0 22 12 61 129 56 14 0 0
Totale 421